Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.

Johnston TP, Zhou X.

J Cardiovasc Pharmacol. 2007 Apr;49(4):246-52.

PMID:
17438410
[PubMed - indexed for MEDLINE]
2.

Acute P-407 administration to mice causes hypercholesterolemia by inducing cholesterolgenesis and down-regulating low-density lipoprotein receptor expression.

Leon C, Wasan KM, Sachs-Barrable K, Johnston TP.

Pharm Res. 2006 Jul;23(7):1597-607. Epub 2006 Jun 21.

PMID:
16783477
[PubMed - indexed for MEDLINE]
3.

Poloxamer 407 (P-407)-mediated reduction in the gene expression of ATP-binding-cassette transporter A1 may contribute to increased cholesterol in peripheral tissues of P-407-treated rats.

Johnston TP, Jaye M, Webb CL, Krawiec JA, Alom-Ruiz SP, Sachs-Barrable K, Wasan KM.

Eur J Pharmacol. 2006 May 1;536(3):232-40. Epub 2006 Mar 20.

PMID:
16603153
[PubMed - indexed for MEDLINE]
4.

Pregnane X receptor-mediated transcription.

Chang TK, Waxman DJ.

Methods Enzymol. 2005;400:588-98.

PMID:
16399372
[PubMed - indexed for MEDLINE]
5.

The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.

Brocks DR, Ala S, Aliabadi HM.

Biopharm Drug Dispos. 2006 Jan;27(1):7-16.

PMID:
16278928
[PubMed - indexed for MEDLINE]
6.

Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339.

Millar JS, Cromley DA, McCoy MG, Rader DJ, Billheimer JT.

J Lipid Res. 2005 Sep;46(9):2023-8. Epub 2005 Jul 1.

PMID:
15995182
[PubMed - indexed for MEDLINE]
Free Article
7.

Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.

Duez H, Lefebvre B, Poulain P, Torra IP, Percevault F, Luc G, Peters JM, Gonzalez FJ, Gineste R, Helleboid S, Dzavik V, Fruchart JC, Fiévet C, Lefebvre P, Staels B.

Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):585-91. Epub 2004 Dec 23.

PMID:
15618549
[PubMed - indexed for MEDLINE]
Free Article
8.

Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.

Shipley JM, Waxman DJ.

Toxicol Appl Pharmacol. 2004 Sep 15;199(3):275-84.

PMID:
15364543
[PubMed - indexed for MEDLINE]
9.

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM.

J Biol Chem. 2004 Sep 24;279(39):40987-93. Epub 2004 Jul 21.

PMID:
15269217
[PubMed - indexed for MEDLINE]
Free Article
10.

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.

Marx N, Duez H, Fruchart JC, Staels B.

Circ Res. 2004 May 14;94(9):1168-78. Review.

PMID:
15142970
[PubMed - indexed for MEDLINE]
Free Article
11.

The P-407-induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date.

Johnston TP.

J Cardiovasc Pharmacol. 2004 Apr;43(4):595-606. Review.

PMID:
15085072
[PubMed - indexed for MEDLINE]
12.

trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals.

Shipley JM, Hurst CH, Tanaka SS, DeRoos FL, Butenhoff JL, Seacat AM, Waxman DJ.

Toxicol Sci. 2004 Jul;80(1):151-60. Epub 2004 Apr 7.

PMID:
15071170
[PubMed - indexed for MEDLINE]
Free Article
14.

Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages.

Chinetti G, Lestavel S, Fruchart JC, Clavey V, Staels B.

Circ Res. 2003 Feb 7;92(2):212-7.

PMID:
12574149
[PubMed - indexed for MEDLINE]
Free Article
15.

Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.

Duez H, Chao YS, Hernandez M, Torpier G, Poulain P, Mundt S, Mallat Z, Teissier E, Burton CA, Tedgui A, Fruchart JC, Fiévet C, Wright SD, Staels B.

J Biol Chem. 2002 Dec 13;277(50):48051-7. Epub 2002 Oct 10.

PMID:
12377786
[PubMed - indexed for MEDLINE]
Free Article
16.

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.

Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, Hoyt RF Jr, Neufeld ED, Remaley AT, Fredrickson DS, Brewer HB Jr, Santamarina-Fojo S.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):407-12. Epub 2001 Dec 18.

PMID:
11752403
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B.

Nat Med. 2001 Jan;7(1):53-8.

PMID:
11135616
[PubMed - indexed for MEDLINE]
18.

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.

Chinetti G, Fruchart JC, Staels B.

Inflamm Res. 2000 Oct;49(10):497-505. Review.

PMID:
11089900
[PubMed - indexed for MEDLINE]
19.

CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.

Chinetti G, Gbaguidi FG, Griglio S, Mallat Z, Antonucci M, Poulain P, Chapman J, Fruchart JC, Tedgui A, Najib-Fruchart J, Staels B.

Circulation. 2000 May 23;101(20):2411-7.

PMID:
10821819
[PubMed - indexed for MEDLINE]
Free Article
20.

Potential downregulation of HMG-CoA reductase after prolonged administration of P-407 in C57BL/6 mice.

Johnston TP, Baker JC, Jamal AS, Hall D, Emeson EE, Palmer WK.

J Cardiovasc Pharmacol. 1999 Dec;34(6):831-42.

PMID:
10598127
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk